We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CBSC market cap is 12.03M. The company's latest EPS is USD -0.0149 and P/E is -5.37.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 59k | 41k | 25k | 76k | 82k |
| Operating Income | -63k | -6k | -3.94M | -1.87M | -2.1M |
| Net Income | -63k | 451k | -6.68M | -6.34M | -2.11M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36k | 5k | 1.69M | 654k | 305k |
| Total Liabilities | 1.07M | 0 | 2.59M | 165k | 682k |
| Total Equity | -1.03M | 5k | -895k | 489k | -377k |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -266k | 354k | -786k | -786k | -1.19M |
| Investing | 24k | N/A | -40k | -40k | 40k |
| Financing | 245k | -357k | 1.23M | 1.23M | 857k |
| Market Cap | 12.03M |
| Price to Earnings Ratio | -5.37 |
| Price to Sales Ratio | 133.33 |
| Price to Cash Ratio | 80 |
| Price to Book Ratio | -30.04 |
| Dividend Yield | - |
| Shares Outstanding | 141.55M |
| Average Volume (1 week) | 14.5k |
| Average Volume (1 Month) | 64.24k |
| 52 Week Change | -43.14% |
| 52 Week High | 0.19 |
| 52 Week Low | 0.04 |
| Spread (Intraday) | 0.01 (7.47%) |
| Company Name | CB Scientific Inc (QB) |
| Address |
4320 s corbett ave portland, oregon 97239 |
| Website | https://www.cbscientificinc.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
